Hemophilia a Trials in Tianjin, China
Conditions / Hemophilia a / Tianjin, China
Hemophilia a has been the subject of sustained clinical investigation across multiple research sites.
31 total trials for this combination
Showing top 10 of 31 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03938792 | Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B | COMPLETED | PHASE3 |
| NCT03417102 | A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors | COMPLETED | PHASE3 |
| NCT01233258 | A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A | COMPLETED | PHASE3 |
| NCT02078427 | ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD) | COMPLETED | — |
| NCT05145127 | Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors | RECRUITING | — |
| NCT04645199 | National Longitudinal Cohort of Hematological Diseases | RECRUITING | — |
| NCT03417245 | A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors | COMPLETED | PHASE3 |
| NCT02476942 | A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment | COMPLETED | — |
| NCT05611801 | A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B | RECRUITING | PHASE3 |
| NCT02492984 | PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A | COMPLETED | PHASE4 |